Third Party Technique

A Letter Writer's Imagination

A doctor who featured in the PR plans of the drug company GlaxoSmithKline has been appointed by the U.S. Food and Drug Administration to a committee reviewing possible links between anti-depressant drugs and suicidality. In December 2004, internal GlaxoSmithKline documents revealed that Dr.

Front Groups Lobbying Spurs Thoughts of Non-Profit Reform

Citing instances where groups like Citizens Against Government Waste and Americans for Tax Reform have accepted corporate funding to lobby for their donors' causes, journalist Bill Adair explores whether greater disclosure by non-profit groups is warranted.

Hyping Heart Attacks

Alan Cassels notes that disease mongering advertisements for cholesterol-lowering drugs, such as for Pfizer's Lipitor, hype the risk of heart attacks for those people with 'high' cholesterol.

Nuclear Public Radio

On its "Weekend Edition Saturday" show, NPR aired a segment titled, "Environmentalists Rethink Stance on Nuclear Power." Who was their one example of an environmentalist turned nuclear power proponent? None other than Greenpeace co-founder turned industry flack Patrick Moore.

Pharma PR Tries to Spin Gold From Yawn

Americans may tire quickly of some pharmaceutical PR, but they've got nowhere to turn (certainly not in bed) when it comes to a new campaign sponsored by the makers of a sleep-fighting medication, Provigil. Drug-maker Cephalon hired Dorland Global Public Relations, which has spun consumers' disinterest in "sleepiness" into a Homeland Security-like campaign for "alertness." The trick: target employers.

Restless Drug Promotion

GlaxoSmithKline breached the British drug industry's own self-regulatory code of conduct by promoting ropinirole to treat restless legs syndrome before the drug had been approved for that use.

Who's Afraid of Eric Schlosser?

"Who made the edit?" asks Evan Hessel in his Forbes "OutFront" column. "The edit" in Wikipedia's entry on McDonald's Corporation erased a link to Eric Schlosser's highly critical assessment of McDonald's in Fast Food Nation, and replaced it with a link to a more academic tome.

Syndicate content